COVID-19
mRNA Vaccine Platform Shows Promise in Boosting Immunity Against Emerging SARS-CoV-2 Variants
Researchers from the California Institute of Technology have developed a novel mRNA vaccine platform that encodes engineered immunogens that induce budding of enveloped virus-like particles (eVLPs) from the plasma membrane, resulting in the presentation of immunogens on cell surfaces and eVLPs. This platform, known as the ESCRT- and ALIX-binding region